Insights

Lisa Yerke, DDS, MS, from University at Buffalo, answers our questions about her research presented during a poster session at the 2018 AIBD Meeting on the use of proton pump inhibitors for IBD and its impact on periodontal disease.

Dr Stephen Hanauer from Northwestern Medicine discusses the roles of TNF inhibitors and immunomodulators in managing IBD, how gastroenterologists can position the use of each therapeutic, and more.

Dr Jean-Frederic Colombel from Mount Sinai Medical Center discusses clinical challenges in inflammatory bowel disease for 2019, the need for a multidisciplinary approach, and more.

Dr Mark Deneau from University of Utah Health discusses the current management of pediatric inflammatory bowel disease and primary sclerosing cholangitis, the importance of identifying patients for treatment, and more.

Dr Sunanda Kane, president of the American College of Gastroenterology, discusses current guidelines for managing severe ulcerative colitis, controversies surrounding rescue treatment, and more.

Dr Stefan Holubar from Cleveland Clinic discusses the management of inflammatory bowel disease among patients with a prior or current malignancy.

Dr Eva Szigethy from University of Pittsburgh Medical Center discusses psychological comorbidities in IBD, how gastroenterologists can approach this, and more.

Dr Eva Szigethy from University of Pittsburgh Medical Center discusses the positive impact of cognitive behavioral therapy in the management of pediatric inflammatory bowel disease.

Dr Miguel Regueiro from Cleveland Clinic discusses different biologic therapeutics for IBD, the importance of understanding side effects, and more.

Dr David Hudesman from NYU Langone discusses why some patients with IBD fail their medication, how gastroenterologists can approach this, and more.